ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999

Panel Urges Research On DCIS To Identify Women At High Risk For Invasive Cancer

September 25, 2009

DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination

October 3, 1986

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011